申请人:Abbott Laboratories
公开号:US05214204A1
公开(公告)日:1993-05-25
The present invention provides certain (substituted carbocyclic aryl)amidoalkyl-and (substituted heterocyclic aryl)amidoalkyl-N-Hydroxy urea compounds which inhibit lipoxygenase enzyme activity and are thus useful in the treatment of allergic and inflammatory disease states.
本发明提供了一些抑制脂氧合酶酶活性的(取代的碳环芳基)氨基烷基和(取代的杂环芳基)氨基烷基-N-羟基脲化合物,因此在治疗过敏和炎症性疾病状态中具有用处。